Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® at the FEMS Congress of European Microbiologists in Hamburg, Germany 9-13 July 2023.
Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® at the FEMS Congress of European Microbiologists in Hamburg, Germany 9-13 July 2023.
Gradientech visar upp sitt ultra-snabba och precisa diagnostiksystem QuickMIC® på europeiska mikrobiologernas kongress FEMS i Hamburg, Tyskland 9-13 juli 2023.
The diagnostics company Gradientech today announces the starting of pre-clinical testing in the US.
Diagnostikföretaget Gradientech AB (publ) meddelar idag att man påbörjar pre-kliniska studier i USA.
Aktieägarna i Gradientech AB, org. nr 556788-9505 (“Bolaget”), kallas härmed till extra bolagsstämma måndagen den 10 juli 2023 klockan 10.00 i Advokatfirman Lindahls lokaler på Vaksalagatan 10 i Uppsala.
Gradientech kommer att presentera lovande resultat från två samarbetsstudier med bolagets ultrasnabba diagnostiksystem QuickMIC® på ASM Microbe i Houston, Texas den 15-19 juni 2023.
Gradientech announces the presentation of promising results from two collaborative studies on its ultra-rapid diagnostic system QuickMIC® at ASM Microbe in Houston, Texas 15 – 19 June 2023.
Gradientech AB (publ) delårsrapport för Q1 2023 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) interim report for Q1 2023 is now available on the company’s website www.gradientech.se.
The diagnostics company Gradientech today announces the appointment of Dr Hilja Ibert and Dr Nedal Safwat to the Gradientech Board of Directors, effective May 9, 2023. Following the new appointments, the Board will comprise six directors.